Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedClinicalTrials.gov’s page footer now shows an updated software revision number, indicating a platform/version update rather than a modification to the underlying study record.SummaryDifference0.0%

- Check28 days agoChange DetectedThe study history shows an addition of Revision: v3.5.2 and a deletion of Revision: v3.5.0.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.5.0 added. The previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision v3.4.3 was added to the history, replacing the previous v3.4.2.SummaryDifference0.0%

- Check92 days agoChange DetectedAdded revision v3.4.2. Removed the funding-status notice and the earlier revision v3.4.1.SummaryDifference0.3%

- Check100 days agoChange DetectedAdded a site-wide notice about government funding status and updated the page revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.